Gazuros Ltd – Trademark Portfolio

Entity Type: 03

Gazuros Ltd has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include NATURE'S BLOSSOM. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 31 (Natural Agricultural Products). This trademark owner is based in Ramat-Hasharon.

4 Yair street

Ramat-Hasharon 4704149 , IL

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Gazuros Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Gazuros Ltd have?

Gazuros Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Gazuros Ltd file in?

Gazuros Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 31 (Natural Agricultural Products), Class 28 (Toys & Sporting Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Gazuros Ltd's most well-known trademarks?

Gazuros Ltd's registered trademark portfolio includes well-known marks such as NATURE'S BLOSSOM. These are among 1 currently registered trademark in the portfolio.

What is Gazuros Ltd's trademark registration success rate?

Gazuros Ltd has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.